Anti-MelanA Antibody [SC56-02]

HUABIO

Anti-MelanA Antibody [SC56-02]

7

ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

WB,IHC-P,FC

Research Use Only

Monoclonal

SC56-02

1 mg/ml

Unconjugated

MLANA

melan-A

MART-1, MART1, melanoma antigen recognized by T-cells 1, antigen LB39-AA, antigen SK29-AA, epididymis secretory sperm binding protein, protein Melan-A

Rabbit

IgG

Melanoma antigen recognized by T-cells 1

Melanoma-associated antigens recognized by cytotoxic T lymphocytes (CTL) have been grouped into three categories: melanocyte differentiation antigens, cancer/testis-specific antigens and mutated or aberrantly expressed antigens. Many of these antigens consist of peptides that are presented to T cells by HLA molecules; they represent potential targets for cancer immunotherapy. Melan-A (also designated MART-1) is a melanocyte differentiation antigen that is specific to melanomas, melanocyte cell lines and retina. Melan-A peptide is recognized by most HLA-A2-restricted tumor-specific tumor-infiltrating lymphocytes in patients with melanoma. Antimelanoma cytotoxic T lymphocytes can be generated with a Melan-A peptide, implicating Melan-A as a potential candidate for antigen-specific immunotherapy in melanoma patients.

Human, Mouse

Human,Mouse

-20°C,2°C to 8°C

41116161